IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Portfolio Profile

CIK: 0001839435 | NEW YORK, NY

Investment Profile

Style

Growth

Turnover

High

Orientation

Concentrated trader
$1.1B
AUM
26
Positions
80.2%
Top 10 Conc.
99.88%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Dianthus Therapeutics Inc(DNTH)1,841,667$179.5M16.14%
2Definium Therapeutics Inc(DFTX)2,950,000$138.8M12.47%
3Abivax SA(ABVX)993,000$132.3M11.89%
4Cogent Biosciences Inc(COGT)2,350,000$90.9M8.17%
5Alumis Inc(ALMS)2,830,700$79.7M7.16%
6

Sector Allocation

Latest filing, equity positions only

Healthcare98.55% · $1.1B
Unclassified1.45% · $15.8M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare99.48%98.55%-0.93%
Unclassified0.52%1.45%+0.93%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$650.9M | 40 pos.
$625.0M | 33 pos.
$834.4M | 57 pos.
$636.3M | 47 pos.
$642.9M | 42 pos.
$607.7M | 33 pos.
Arrivent Biopharma Inc(AVBP)
1,971,054
$68.5M
6.15%
7Taysha Gene Therapies Inc(TSHA)9,693,244$66.0M5.93%
8Bioage Labs Inc(BIOA)1,748,000$42.8M3.85%
9Mirum Pharmaceuticals Inc(MIRM)338,900$39.7M3.57%
10Kymera Therapeutics Inc(KYMR)310,000$35.5M3.20%
Cap SizePrev %Curr %Change
Mid Cap67.27%68.45%+1.18%
Small Cap26.33%23.96%-2.37%
Micro Cap5.88%4.48%-1.4%
Large Cap0%1.67%+1.67%
Unclassified0.52%1.45%+0.93%
$516.8M | 35 pos.
$455.6M | 30 pos.
$659.8M | 27 pos.
$823.7M | 27 pos.
$903.6M | 29 pos.
$1.1B | 27 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
7
Closed
4
Increased
6
Decreased
12
Unchanged